NEW YORK, May 23, 2019 /PRNewswire/
-- Oppenheimer & Co. Inc. ("Oppenheimer") – a
leading investment bank, wealth manager, and a subsidiary of
Oppenheimer Holdings (NYSE: OPY) – will host its first MedTech Day
on May 29, 2019 at the Hilton Union
Square in San Francisco, CA. The
event will bring together 15 leading companies in the medical
technology (MedTech) space and feature 1-on-1 meetings between
investors and industry leaders.
"MedTech Day creates a collaborative space for companies to meet
with Oppenheimer's institutional clients, thus creating synergies
between the two," said Michael
Margolis, R.Ph., Co-Head of Healthcare Investment Banking.
Oppenheimer analysts, Steven
Lichtman, Managing Director and Senior Analyst covering
Medical Devices, and Kevin DeGeeter,
Managing Director and Senior Analyst covering Biotechnology, will
be attending to offer valuable industry insights to clients based
on the current landscape.
"MedTech is the next frontier in healthcare; state-of-the-art
technologies and emerging therapies have the potential to
fundamentally alter how the industry operates, creating new
opportunities for patients, doctors and healthcare professionals
alike and we are pleased to offer this one-day session for the
companies," added Margolis.
The lunch panel session titled, Current Trends and Future
Outlook in Diabetes Devices, features prominent speakers
including Dr. Saleh Adi, an
independent consultant in the field of diabetes technology and the
Founding Director of the Madison Clinic for Pediatric Diabetes at
University of California, San
Francisco, and Dr. Linda
Glaser, MD, PhD, Medical Director of Coastal Biomedical
Research and an Endocrinologist in a solo private practice.
"Our goal with this first MedTech Day in San Francisco is to create a collective space
for investors to interact with innovative, industry-leading
companies and professionals, because our clients recognize the
tremendous opportunities these organizations present," said
Erica L. Moffett, Managing Director
and Associate Director of Equity Research at Oppenheimer.
Oppenheimer's upcoming conferences include the inaugural Montauk
Summit for Emerging Life Science Companies. The event will feature
approximately 25 emerging Life Sciences companies as well as the
2018 Nobel Prize winner for Medicine, Dr. Jim Allison, as a member of the Checkmates, a
band comprised of leading scientists, researchers and executives at
the MD Anderson Cancer Center. Oppenheimer is also hosting
the 19th Annual Consumer Growth & E-Commerce Conference on
June 18-19 and the 22nd Annual
Technology, Internet & Communications Conference on
August 6-7, both of which will be
held in Boston, Massachusetts.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc.
(Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc.
(OPY on the New York Stock Exchange), and its affiliates provide a
full range of wealth management, securities brokerage and
investment banking services to high-net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
View original
content:http://www.prnewswire.com/news-releases/leading-medical-companies-and-investors-gather-in-san-francisco-for-oppenheimers-medtech-day-300856197.html
SOURCE Oppenheimer & Co. Inc.